NXL
Nexalin Technology, Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Last price
0.35
▲ 0.02 (5.44%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
0.33
Prev close
0.33
Day high
0.33
Day low
0.33
Volume
70.40K
Market cap
$7.32M
P/E (TTM)
—
52W range
0.31 – 2.00
Day trading desk
Gap from prior close
+0.45%
Prior close 0.33
VWAP
0.33
+5.19% from price
Relative volume
0.22×
Quiet session
Session range
6.28%
0.33 – 0.35
Position in range
100%
Near session high
ATR (14D)
0.03
7.60% of price
Prior day high
0.35
PDH
Prior day low
0.32
PDL
Bid / ask spread
—
Quote not published
Session volume
65.26K
Avg 293.85K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-5.14%
-3.8%
1M
-29.06%
-32.8%
3M
-16.79%
-19.9%
6M
-33.33%
-44.4%
YTD
-40.50%
-52.8%
1Y
-53.89%
-73.9%
3Y
-45.57%
-119.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on NXL open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
2.05M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 29, 25 | OSSER LEONARD A Beneficial Owner of more than 10% of a Class of Security |
STOCK | 83.33K | $0 | Indirect |
| Sep 29, 25 | HU BENJAMIN Director |
STOCK | 36.46K | $0 | Direct |
| Sep 29, 25 | OWENS DAVID Officer and Director |
STOCK | 36.46K | $0 | Direct |
| Sep 29, 25 | KAZDEN ALAN Director |
STOCK | 36.46K | $0 | Indirect |
| Mar 12, 25 | SHELTON CAROLYN HAMBY Officer |
BUY | 6.00K | $13.20K | Indirect |
| Feb 4, 25 | OWENS DAVID Officer and Director |
BUY | 1.00K | $2.98K | Direct |
| Feb 4, 25 | OWENS DAVID Officer and Director |
BUY | 1.00K | $3.10K | Direct |
| Jan 28, 25 | OWENS DAVID Officer and Director |
BUY | 1.50K | $4.05K | Direct |
| Jan 23, 25 | OWENS DAVID Officer and Director |
BUY | 3.00K | $7.70K | Direct |
| Dec 20, 24 | OWENS DAVID Officer and Director |
BUY | 1.00K | $2.75K | Direct |
| Oct 28, 24 | OWENS DAVID Officer and Director |
BUY | 500 | $1.09K | Direct |
| Oct 14, 24 | SHELTON CAROLYN HAMBY Officer |
BUY | 24.00K | $20.40K | Direct |
| Sep 30, 24 | BERNHARD LESLIE Director |
STOCK | 49.84K | $0 | Direct |
| Sep 30, 24 | ELSON MARILYN Beneficial Owner of more than 10% of a Class of Security |
STOCK | 700.00K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BERNHARD LESLIE |
Director | 49.84K | Stock Award(Grant) |
ELSON MARILYN |
Beneficial Owner of more than 10% of a Class of Security | 1.54M | Stock Award(Grant) |
HU BENJAMIN |
Director | 377.10K | Stock Award(Grant) |
KAZDEN ALAN |
Director | — | Stock Award(Grant) |
OSSER LEONARD A |
Beneficial Owner of more than 10% of a Class of Security | — | Stock Award(Grant) |
OWENS DAVID |
Officer and Director | 191.25K | Stock Award(Grant) |
SHELTON CAROLYN HAMBY |
Officer | — | Purchase |
Fundamentals
Market cap$7.32M
Enterprise value$6.31M
Revenue (TTM)$217.16K
Gross profit$187.10K
EBITDA$-9.08M
Net income$-8.99M
EPS (TTM)$-0.46
Free cash flow$-2.53M
Total cash$1.00M
Total debt$0
Book value / share$0.07
Shares outstanding22.04M
Float19.32M
Short % of float1.52%
Dividend yield—
Beta (5Y)4.04
Valuation & profitability ratios
Trailing P/E—
Forward P/E-1.07
PEG ratio—
Price / sales—
Price / book4.81
EV / revenue29.07
EV / EBITDA-0.70
Gross margin86.16%
Operating margin-18479.69%
Profit margin0.00%
Return on equity-240.25%
Return on assets-119.22%
Debt / equity—
Current ratio1.25
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $301.65K | $168.72K | $110.75K | $1.32M | +78.8% |
| Operating revenue | $274.16K | $162.83K | $109.38K | $1.29M | +68.4% |
| Cost of revenue | $61.37K | $36.59K | $25.69K | $363.21K | +67.7% |
| Gross profit | $240.27K | $132.13K | $85.06K | $958.14K | +81.8% |
| Research & development | $1.08M | $1.19M | $1.92M | — | -9.0% |
| Selling, general & admin | $7.55M | $6.70M | $3.86M | $2.79M | +12.7% |
| Total operating expense | $8.63M | $7.89M | $5.78M | $2.79M | +9.4% |
| Operating income | -$8.39M | -$7.75M | -$5.70M | -$1.83M | -8.2% |
| Net interest income | $8.24K | $3.19K | -$38.84K | -$59.38K | +158.1% |
| Pre-tax income | -$8.22M | -$7.61M | -$4.65M | -$1.70M | -8.0% |
| Tax provision | $0 | $0 | $0 | — | — |
| Net income | -$8.22M | -$7.61M | -$4.65M | -$1.70M | -8.1% |
| Net income to common | -$8.22M | -$7.61M | -$4.65M | -$1.70M | -8.1% |
| Basic EPS | -0.50 | -0.83 | -0.63 | -0.30 | +39.8% |
| Diluted EPS | -0.50 | -0.83 | -0.63 | -0.30 | +39.8% |
| EBIT | -$8.39M | -$7.75M | -$5.70M | -$1.83M | -8.2% |
| EBITDA | -$8.37M | -$7.74M | -$5.69M | -$1.83M | -8.1% |
| Basic shares | 16.39M | 9.22M | 7.36M | 5.57M | +77.9% |
| Diluted shares | 16.39M | 9.22M | 7.36M | 5.57M | +77.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $654.78K | $574.49K | $580.23K | $162.74K | — | +14.0% |
| Cash & short-term investments | $3.72M | $3.48M | $2.95M | $6.99M | — | +7.0% |
| Accounts receivable | $81.57K | $13.04K | $9.37K | $4.88K | — | +525.4% |
| Inventory | $131.47K | $174.58K | $156.42K | $154.37K | — | -24.7% |
| Total current assets | $4.30M | $3.96M | $3.43M | $7.43M | — | +8.5% |
| Property, plant & equipment | — | $0 | $496 | $6.67K | $1.04K | — |
| Goodwill & intangibles | $336.05K | $260.73K | $105.53K | $0 | — | +28.9% |
| Total assets | $4.64M | $4.22M | $3.63M | $7.43M | — | +9.8% |
| Total current liabilities | $887.33K | $546.69K | $425.28K | $1.95M | — | +62.3% |
| Current debt | — | — | — | $700.00K | $737.20K | — |
| Long-term debt | — | — | — | — | $22.92K | — |
| Total debt | — | $0 | $4.46K | $755.26K | $850.05K | — |
| Total liabilities | $887.33K | $546.69K | $425.28K | $1.95M | — | +62.3% |
| Retained earnings | -$92.87M | -$84.65M | -$77.04M | -$72.39M | — | -9.7% |
| Shareholder equity | $3.75M | $3.68M | $3.21M | $5.48M | — | +2.0% |
| Working capital | $3.41M | $3.41M | $3.00M | $5.48M | — | -0.1% |
| Net tangible assets | $3.41M | $3.42M | $3.10M | $5.48M | — | -0.1% |
| Shares issued | 19.19M | 13.30M | 7.44M | 7.29M | — | +44.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$8.22M | -$7.61M | -$4.65M | -$1.70M | -8.1% |
| Depreciation & amortisation | $21.54K | $15.11K | $4.25K | $535 | +42.6% |
| Stock-based compensation | $3.12M | $3.56M | $2.41M | $270.67K | -12.3% |
| Change in working capital | $229.42K | $121.65K | -$768.86K | -$634.07K | +88.6% |
| Operating cash flow | -$4.96M | -$3.94M | -$3.84M | -$2.22M | -25.7% |
| Capital expenditure | -$96.86K | -$170.31K | -$109.28K | — | +43.1% |
| Investing cash flow | -$131.99K | -$577.54K | $4.45M | -$6.79M | +77.1% |
| Financing cash flow | $5.17M | $4.52M | -$200.00K | $8.51M | +14.5% |
| Free cash flow | -$5.05M | -$4.11M | -$3.94M | -$2.22M | -22.8% |
| End cash position | $654.78K | $574.49K | $580.23K | $162.74K | +14.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $14.95K | $171.90K | $18.15K | $70.59K | $41.02K | -91.3% |
| Operating revenue | $14.95K | $144.40K | $18.15K | $70.59K | $41.02K | -89.6% |
| Cost of revenue | $1.82K | $21.03K | $3.95K | $22.84K | $13.56K | -91.4% |
| Gross profit | $13.13K | $150.87K | $14.20K | $47.75K | $27.46K | -91.3% |
| Research & development | $346.38K | $224.94K | $226.52K | $225.77K | $406.29K | +54.0% |
| Selling, general & admin | $1.79M | $2.34M | $2.13M | $1.44M | $1.63M | -23.6% |
| Total operating expense | $2.13M | $2.56M | $2.36M | $1.67M | $2.04M | -16.8% |
| Operating income | -$2.12M | -$2.41M | -$2.35M | -$1.62M | -$2.01M | +12.2% |
| Net interest income | $34 | $159 | $2.29K | $4.69K | $1.10K | -78.6% |
| Pre-tax income | -$2.10M | -$2.38M | -$2.28M | -$1.58M | -$1.99M | +11.8% |
| Tax provision | $0 | $0 | $0 | $0 | $0 | — |
| Net income | -$2.10M | -$2.38M | -$2.28M | -$1.58M | -$1.99M | +11.8% |
| Net income to common | -$2.10M | -$2.38M | -$2.28M | -$1.58M | -$1.99M | +11.8% |
| Basic EPS | -0.11 | — | -0.13 | -0.10 | -0.15 | — |
| Diluted EPS | -0.11 | — | -0.13 | -0.10 | -0.15 | — |
| EBIT | -$2.12M | -$2.41M | -$2.35M | -$1.62M | -$2.01M | +12.2% |
| EBITDA | -$2.11M | -$2.41M | -$2.34M | -$1.62M | -$2.01M | +12.4% |
| Basic shares | 19.82M | — | 17.79M | 15.72M | 13.31M | — |
| Diluted shares | 19.82M | — | 17.79M | 15.72M | 13.31M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.21M | $654.78K | $590.08K | $431.32K | $622.03K | — | +84.5% |
| Cash & short-term investments | $2.71M | $3.72M | $4.35M | $5.79M | $2.05M | — | -27.3% |
| Accounts receivable | $43.00K | $81.57K | $7.92K | $59.84K | $11.08K | — | -47.3% |
| Inventory | $179.49K | $131.47K | $160.22K | $172.97K | $175.25K | — | +36.5% |
| Total current assets | $3.29M | $4.30M | $4.82M | $6.27M | $2.62M | — | -23.5% |
| Property, plant & equipment | $45.17K | — | — | — | — | $0 | — |
| Goodwill & intangibles | $359.31K | $336.05K | $308.56K | $294.87K | $279.52K | — | +6.9% |
| Total assets | $3.69M | $4.64M | $5.13M | $6.56M | $2.90M | — | -20.3% |
| Total current liabilities | $808.36K | $887.33K | $357.52K | $600.58K | $574.74K | — | -8.9% |
| Total debt | — | — | — | — | — | $0 | — |
| Total liabilities | $808.36K | $887.33K | $357.52K | $600.58K | $574.74K | — | -8.9% |
| Retained earnings | -$94.96M | -$92.87M | -$90.49M | -$88.21M | -$86.63M | — | -2.3% |
| Shareholder equity | $2.89M | $3.75M | $4.77M | $5.96M | $2.33M | — | -23.0% |
| Working capital | $2.48M | $3.41M | $4.46M | $5.67M | $2.05M | — | -27.3% |
| Net tangible assets | $2.53M | $3.41M | $4.46M | $5.67M | $2.05M | — | -25.9% |
| Shares issued | 20.58M | 19.19M | 18.19M | 17.42M | 13.33M | — | +7.3% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$2.10M | -$2.38M | -$2.28M | -$1.58M | -$1.99M | +11.8% |
| Depreciation & amortisation | $10.84K | $6.15K | $5.47K | $5.13K | $4.79K | +76.3% |
| Stock-based compensation | $478.61K | $831.53K | $1.08M | $572.10K | $636.84K | -42.4% |
| Change in working capital | -$84.58K | $402.07K | -$231.44K | $119.03K | -$60.25K | -121.0% |
| Operating cash flow | -$1.71M | -$1.15M | -$1.47M | -$917.16K | -$1.43M | -49.2% |
| Capital expenditure | -$79.27K | -$33.64K | -$19.16K | -$20.48K | -$23.58K | -135.7% |
| Investing cash flow | $1.51M | $689.18K | $1.63M | -$3.92M | $1.47M | +119.1% |
| Financing cash flow | $756.42K | $523.55K | $0 | $4.65M | $0 | +44.5% |
| Free cash flow | -$1.79M | -$1.18M | -$1.49M | -$937.64K | -$1.45M | -51.7% |
| End cash position | $1.21M | $654.78K | $590.08K | $431.32K | $622.03K | +84.5% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.10 | -0.11 | -10.0% |
| Mar 2026 | -0.10 | -0.11 | -10.0% |
| Dec 2025 | -0.12 | -0.13 | -8.3% |
| Sep 2025 | -0.12 | -0.13 | -8.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.09 | 1 | $90.00K | +395.9% |
| Next quarter | -0.09 | 1 | $150.00K | -12.7% |
| Current year | -0.38 | 1 | $345.00K | +14.4% |
| Next year | -0.31 | 1 | $690.00K | +100.0% |
Analyst targets & ownership
Mean target$2.00
High target$2.00
Low target$2.00
Implied upside473.72%
Analyst count1
ConsensusNONE
Strong buy / Buy1 / 0
Hold0
Sell / Strong sell0 / 0
Held by insiders9.29%
Held by institutions3.45%
Institutions holding21
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.34
+1.93% from price
SMA 20
0.35
-5.09% from price
SMA 50
0.39
-13.84% from price
SMA 100
0.40
-13.24% from price
SMA 200
0.55
-40.01% from price
EMA 12
0.34
+1.19% from price
EMA 26
0.36
-4.28% from price
EMA 50
0.38
-9.24% from price
RSI (14)
40.4
Neutral
MACD (12,26,9)
-0.02
Hist -0.00
ATR (14)
0.03
7.98% of price
Realised vol 30D
114.0%
Annualised
Bollinger upper
0.40
20, 2σ
Bollinger lower
0.30
20, 2σ
50 / 200 cross
Death
0.39 vs 0.55
Trend bias
Below 200
-40.01%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.94
More volatile than market
Correlation to SPY
0.17
Largely independent
Realised vol 30D
114.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-82.7%
Peak to trough
Max drawdown 5Y
-92.6%
Peak to trough
ATR 14
0.03
7.98% of price
Beta (reported)
4.04
5Y monthly, from filing
Short interest
Shares short
323.37K
Prior 540.63K
Change vs prior
-40.2%
Shorts covering
% of float
1.52%
Normal
% of shares out
1.47%
Against total outstanding
Days to cover
1.2
Liquid
Float
19.32M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 24, 25 | Maxim Group | UPGRADE | Hold | Buy |
| Dec 5, 24 | Maxim Group | DOWNGRADE | Buy | Hold |
| Oct 9, 24 | Maxim Group | INITIATED | — | Buy |
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-21
Corporate Changes & Voting Matters
8-K · 2026-08-20
Corporate Changes & Voting Matters
8-K · 2026-08-17
Periodic Financial Reports
10-Q · 2026-08-12
Corporate Changes & Voting Matters
8-K · 2026-08-11
Corporate Changes & Voting Matters
8-K · 2026-07-29
Corporate Changes & Voting Matters
8-K · 2026-07-27
Proxy Statements
PRE 14A · 2026-06-29
Headlines
NexaLine Technology Registers 1.2 Million Shares for Resale
MT Newswires · 55d ago
Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s Proprietary DIFS™ Platform
GlobeNewswire · 61d ago
Nexalin Technology Announces Two Clinical Abstracts Accepted for Presentation at the 2026 NYC Neuromodulation Conference Highlighting Preliminary Clinical Results Across Anxiety, Depression, Insomnia and Quality of Life
GlobeNewswire · 68d ago
Nexalin Study Shows Strong Anxiety and Depression Response in Brazil Trial
MT Newswires · 74d ago
Nexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across Depression, Insomnia and Quality of Life as Company Advances Brazilian Sales Plan.
GlobeNewswire · 74d ago
EXCLUSIVE: Nexalin Brazil Trial Shows Benefits Across Anxiety, Sleep And Quality Of Life
Benzinga · 74d ago
Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia
GlobeNewswire · 80d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.